Showing results (531-540 of 623) with videos related to
Sort By:
Pageof 63
Cancer|August 13, 2015
Phase 2 study of sunitinib in patients with metastatic mucosal or acral melanomaElizabeth I Buchbinder, Jeffrey A Sosman, Donald P Lawrence, et al.Oncoimmunology|November 20, 2013
BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytesZachary A Cooper, Dennie T Frederick, Vikram R Juneja, et al.Annals of Neurology|February 23, 2020
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing SpectrumDivyanshu Dubey, William S David, Kerry L Reynolds, et al.Cancer Research Communications|April 29, 2024
A Phase II Study of ERK Inhibition by Ulixertinib (BVD-523) in Metastatic Uveal MelanomaElizabeth I Buchbinder, Justine V Cohen, Giuseppe Tarantino, et al.Seminars in Arthritis and Rheumatism|November 10, 2018
Musculoskeletal rheumatic complications of immune checkpoint inhibitor therapy: A single center experienceMeghan J Mooradian, Mazen Nasrallah, Justin F Gainor, et al.North American Spine Society Journal|February 5, 2025
The effect of time to balloon kyphoplasty on osteoporotic vertebral compression fractures: a systematic review with meta-analysisMonis A Khan, Haroon Kisana, Conner Clay, et al.The Journal of Investigative Dermatology|December 30, 2019
Melanin has a Small Inhibitory Effect on Cutaneous Vitamin D Synthesis: A Comparison of Extreme PhenotypesAntony R Young, Kylie A Morgan, Tak-Wai Ho, et al.Cancer Immunology, Immunotherapy : CII|January 13, 2015
Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor β by the monoclonal antibody fresolimumab (GC1008)Mario E Lacouture, John C Morris, Donald P Lawrence, et al.Rural and Remote Health|November 5, 2015
Evaluating the impact of a community developed collaborative project for the prevention of early childhood caries: the Healthy Smile Happy Child projectRobert J Schroth, Jeanette M Edwards, Douglas J Brothwell, et al.The Oncologist|May 7, 2017
Impact of Age on Outcomes with Immunotherapy for Patients with MelanomaAllison S Betof, Ryan D Nipp, Anita Giobbie-Hurder, et al.Pageof 63